title: Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report.
authors.affiliation: Department of Obstetrics and Gynecology, Hacettepe University, School of Medicine, Ankara, Turkey.
authors.forename: C
authors.initials: C
authors.lastname: Baykal
authors.forename: N
authors.initials: N
authors.lastname: Zengin
authors.forename: F
authors.initials: F
authors.lastname: Coşkun
authors.forename: N
authors.initials: N
authors.lastname: Güler
authors.forename: A
authors.initials: A
authors.lastname: Ayhan
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage* / Q000009:adverse effects; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea